Ospemifene in the treatment of vulvovaginal atrophy.

about

Personal opinion: Treatment of vulvovaginal atrophy--are hidden interests and misinformation preventing better management?

P2860

Q40511078-3DB97C39-D148-4D74-8CFE-7D15BD21AE76

P2860

Ospemifene in the treatment of vulvovaginal atrophy.

Item

http://www.wikidata.org/entity/Q38194966

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Ospemifene in the treatment of vulvovaginal atrophy.

@en

type

Item

label

Ospemifene in the treatment of vulvovaginal atrophy.

@en

prefLabel

Ospemifene in the treatment of vulvovaginal atrophy.

@en

P1476

Ospemifene in the treatment of vulvovaginal atrophy.

@en

P2093

Abigail M Yancey

http://www.w3.org/2001/XMLSchema#string

Alicia B Forinash

http://www.w3.org/2001/XMLSchema#string

Erica F Pearce

http://www.w3.org/2001/XMLSchema#string

Kylie N Barnes

http://www.w3.org/2001/XMLSchema#string

P2860

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

Vulvovaginal atrophy.

Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: results from a pivotal phase 3 study.

The 2012 hormone therapy position statement of: The North American Menopause Society.

Selective estrogen-receptor modulators -- mechanisms of action and application to clinical practice.

Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy.

Barriers to effective treatment of vaginal atrophy with local estrogen therapy.

The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.

P304

752-757

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1060028014526036

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24615631

http://www.w3.org/2001/XMLSchema#string

Ospemifene in the treatment of vulvovaginal atrophy.

about

P2860

P2860

Ospemifene in the treatment of vulvovaginal atrophy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698